RxDoctor Payments Data

Bertha Hambidge, MD

Psychiatry · Fort Bragg, NCNPI 1043824998

Payments from drug & device makers

$3,793in general payments, 2019–2025

Across 205 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$765
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$613
  • Alkermes, Inc.$415
  • Neurocrine Biosciences, Inc.$332
  • AbbVie$331
  • Teva Pharmaceuticals USA, Inc.$298
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$3,73999%
  • Education$531%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,793 in reported general payments places this provider in the 85th percentile of 1,108 psychiatry providers in North Carolina.

See all psychiatry providers in North Carolina

Medicare billing

Part B allowed, 2024
$6,388
Medicare patients
42
Services billed
83

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate59$485,726
VraylarCariprazine Hcl54$70,250
Invega SustennaPaliperidone Palmitate27$66,984
RexultiBrexpiprazole18$25,988
PerserisRisperidone11$25,018
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl46$3,202
Clozapine23$2,328
Vilazodone Hcl20$2,075
Duloxetine Hcl81$1,398
Olanzapine74$1,314
Hydroxyzine Hcl50$1,208
Trazodone Hcl127$1,190
Hydroxyzine Pamoate57$1,147
Desvenlafaxine Succinate ErDesvenlafaxine Succinate46$1,072
Haloperidol Decanoate27$1,047

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$332$485,72659 claims
AbbVieVraylar$331$70,25054 claims
Johnson & JohnsonInvega Sustenna$254$66,98427 claims
Otsuka America Pharmaceutical, Inc.Rexulti$765$25,98818 claims
Indivior Inc.Perseris$13$25,01811 claims
Almatica Pharma LLCSertraline Hcl$82$11628 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,108 psychiatry providers in North Carolina.

Other psychiatry in Fort Bragg

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →